QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
Roquette Announces New Organizational Structure Following IFF Pharma Solutions Acquisition

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new organizati...

May 05, 2025 | Monday | News
Roquette Completes Acquisition of IFF Pharma Solutions, Strengthens Global Pharma Leadership

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful complet...

May 01, 2025 | Thursday | News
Merck Makes $3.9 Billion Bet on Rare Tumors With SpringWorks Therapeutics Acquisition

  Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $...

April 29, 2025 | Tuesday | News
Principle Health Systems Acquires Heartland Health Laboratory, Expanding Diagnostic Services in the Midwest

Principle Health Systems (PHS), the leading mobile diagnostic provider for the long-term care community, is pleased to announce the acquisition of Heartlan...

April 22, 2025 | Tuesday | News
INVO Fertility Rebrands and Refocuses on Fertility Services, Separates Oncology Operations

INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment t...

April 15, 2025 | Tuesday | News
Rhythm Pharmaceuticals Reacquires Rights to IMCIVREE® (setmelanotide) in China, Hong Kong, and Macau

 Rhythm Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neur...

March 24, 2025 | Monday | News
iOncologi Acquires TargImmune to Advance Next-Gen RNA Immunotherapies for Solid Tumors

iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies,  announced the acquisition of ...

March 17, 2025 | Monday | News
23andMe Board Rejects CEO Anne Wojcicki’s Lowball Buyout Offer, Raising Big Questions for Investors

The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed ...

March 04, 2025 | Tuesday | Analysis
Novartis to Acquire Anthos Therapeutics, Advancing Development of Abelacimab for Stroke and Thrombosis Prevention

Novartis announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceut...

February 12, 2025 | Wednesday | News
Alumis and ACELYRIN Announce Definitive Merger Agreement, Creating a Leading Immunology Biopharma with Late-Stage Pipeline Strength

Alumis Inc. (Nasdaq: ALMS) and ACELYRIN, Inc. (Nasdaq: SLRN) today announced a definitive merger agreement, creating a powerhouse in immunology-focused b...

February 07, 2025 | Friday | News
Ardena Expands into North America with Acquisition of Catalent’s Drug Manufacturing Facility in New Jersey

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) wit...

February 05, 2025 | Wednesday | News
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching Expanded Global CDMO Operations

Tanvex BioPharma, Inc.  (“Tanvex”), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars product...

January 20, 2025 | Monday | News
Eli Lilly to Acquire Scorpion Therapeutics’ PI3Kα Inhibitor STX-478 for Advanced Solid Tumors

 Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology company developing small ...

January 14, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close